Like other new tools in the drug discovery process, automation, implemented properly, can generate the insight necessary to drive the pharmaceutical business forward.
The FDA has increased its focus on modernizing the regulation of pharmaceutical manufacturing and drug product quality. As a result, innovative pharmaceutical companies are re-examining whether traditional drug development and commercialization processes are sufficient.